IndraLab
Statements
reach
"Inhibition of EGFR activity using cetuximab partially abrogated the feedback activation of phosphorylated receptor tyrosine protein kinase erB-3 (p-HER3) and p-AKT serine/threonine kinase (AKT), as well as prevented reactivation of p-extracellular regulated kinase (ERK) conferred by AZD6244 treatment."
reach
"The in vivo assay demonstrated that EGFR and SOS1 promoted growth of nuclear p-AKT +, Bcl-2 + cells results in the resistance of hepatoma cells to ASPP2 and p53 complex induced apoptosis and that blocking nuclear translocation of EGFR dramatically improves and enhances the pro apoptotic function of ASPP2."
reach
"As shown in XREF_FIG, when compared to the vector control, expression of Dock180 WT had a minimal impact on EGFRvIII stimulated p-Akt, p-Erk1/2 and Rac1 activity whereas expression of Dock180 S1250L attenuated EGFRvIII stimulation of p-Erk1/2 and Rac1 activity but had no effect on p-Akt."